Urethritis is an inflammation of the urethra. Urethritis is described as either gonococcal, when Neisseria gonorrhoeae gonorrhea is detected and the absence of it is called non-gonococcal urethritis classified under sexually transmitted urethritis. In men the primary pathogens associated with urethritis are Chlamydia trachomatis and Neisseria gonorrhoeae. To stops the growth of or kills bacteria and to relieve from painful condition the patients are treated with antibiotics, analgesics, antibacterial etc.
According to Antimicrobe, urethritis occurs in 4 million Americans each year and as per the Department of Health, U.K., and urethritis accounts for 0.005% of hospital consulting with a high 97% of hospital consulting for urethritis requiring hospital admission. Almost 20% of hospital admissions for urethritis requires an emergency.
Urethritis Market Outlook
- Increasing demand for the treatment due to growing population with urethritis, increasing screening, rising number of geriatric population, rising safety and success of drug treatment are driving the growth of the market
- However, the bacterial resistance for antibacterial, side effects due to drug treatment and high cost of the medication is expected to impede the market growth
Urethritis Market COVID-19 Impact
- The global pandemic of Coronavirus (COVID-19) has triggered stock market instability, tight border controls, and worldwide lockdown, leading the healthcare industry, as well as large companies and governments, to restock supply chains
- The whole world is experiencing severe impact on social and financial sectors, and all global industries are facing challenges during the COVID-19 pandemic
- Rising support from governments and several companies can help in the fight against this highly contagious disease
- There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic
Urethritis Market Segmental Highlights
- The urethritis market is segmented by type, treatment, end users and geography
- Basically urethritis is of two type of infective urethritis and nonspecific urethritis. The non-specific urethritis is an inflammation of a man’s urethra that is not caused by gonorrhoea i.e. a sexually transmissible infection. It is also called non-gonococcalurethritis
- Urethritis can be treated with antibacterial, antiviral and pain killers. Moreover, the urethritis associated with reactive arthritis is treated with non-steroidal anti-inflammatory drugs such as naproxen. Antibacterial agents used massively are ciprofloxacin, azithromycin and doxycycline
- The drugs for treatment of urethritis are utilized in hospitals, clinics and research and academic institutes. Also it is used in diagnostic laboratories and the use is expected to grow rapidly due to increasing collaboration of hospitals and diagnostic centers
Urethritis Market by Geography
The urethritis market is analyzed across the various regions geographically such as North America, Europe, Asia Pacific and rest of world. In 2019, the North America dominated the global market due to advanced diagnosis of infection and treatment provided to the population. Moreover, Asia-Pacific market is estimated to be the fastest growing region during the forecast period, due to increase in the number of urethritis population and rising prevalence rate of infections etc.
Urethritis Market Key Players
Major market players in urethritis market are GlaxoSmithKline plc. Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Merck & Co., Inc., AbbVie, AstraZeneca plc. Eli Lilly and Company, Bristol-Myers Squibb, Bayer AG and Johnson & Johnson. Main players operating in this market are focusing on treatment advancements for urethritis by launching new drugs to enhance the market share.
The urethritis market is segmented by type, treatment, end users and geography. Basically urethritis is of two type of infective urethritis and nonspecific urethritis. The medication for urethritis are utilized in hospitals, clinics and research and academic institutes. Also it is used in diagnostic laboratories and the use is predicted to grow rapidly due to increasing collaboration of hospitals and diagnostic centers.
Antibacterial, antiviral and pain killers are used in the treatment of Urethritis. Antibacterial agents used massively are ciprofloxacin, azithromycin and doxycycline. The urethritis market is evaluated across the various regions geographically such as North America, Europe, Asia Pacific and rest of world. In 2019, the North America dominated the global market due to advanced diagnosis of infection and treatment provided to the population.
Why to buy this report:
- The report offers changing market dynamics in the urethritis market, presenting historical, current and projected market size in terms of value (USD Million)
- The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of urethritis market
- It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the urethritis market
- The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of urethritis market
